Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)
Polycystic Kidney Diseases Therapeutics Market Report 2024: Comprehensive Insights About 8+ Companies and 10+ Pipeline Drugs [Yahoo! Finance]
Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences [Yahoo! Finance]